Jennifer Petter

Jennifer Petter

Company: Arrakis Therapeutics

Job title: Founder and Chief Innovation Officer

Seminars:

Live Q&A & Panel Discussion: Debating Between Strategies to Obtain Critical & Valuable Structural RNA Insights 10:40 am

For years, frontiers of the field have harnessed various innovative strategies to unlock structural information to streamline the successful discovery and development of RNA targeted small molecules. This panel will unite the leaders of the field to compare, contrast and debate between approaches and successes in RNA structure-based drug design.Read more

day: Day One

Drugging RNA – A Structure-Based Approach 10:15 am

Discussing the breadth of opportunity offered by drugging RNA Outlining target selection and screening Deeper dive into target structureRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.